Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers

BACKGROUND: Venous thromboembolism (VTE) is a complex disease with an incidence rate of about 1 in 1000 per year. Despite the availability of validated biomarkers for VTE, unprovoked events account for 50% of first events. Therefore, emerging high‐throughput proteomics are promising methods for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Faquih, Tariq, Mook‐Kanamori, Dennis O., Rosendaal, Frits R., Baglin, Trevor, Willems van Dijk, Ko, van Hylckama Vlieg, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110437/
https://www.ncbi.nlm.nih.gov/pubmed/34013156
http://dx.doi.org/10.1002/rth2.12526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110437/
https://www.ncbi.nlm.nih.gov/pubmed/34013156
http://dx.doi.org/10.1002/rth2.12526

Ejemplares similares